On Tuesday, RxSight Inc (NASDAQ: RXST) was 0.85% up from the session before settling in for the closing price of $14.20. A 52-week range for RXST has been $13.50 – $66.54.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 172.93% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 7.06%. With a float of $38.38 million, this company’s outstanding shares have now reached $40.43 million.
In an organization with 498 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 65.95%, operating margin of -24.57%, and the pretax margin is -18.27%.
RxSight Inc (RXST) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward RxSight Inc stocks. The insider ownership of RxSight Inc is 5.22%, while institutional ownership is 91.62%. The most recent insider transaction that took place on Mar 12 ’25, was worth 180,002. In this transaction Director of this company sold 7,000 shares at a rate of $25.71, taking the stock ownership to the 24,793 shares. Before that another transaction happened on Mar 12 ’25, when Company’s Director proposed sale 7,000 for $25.71, making the entire transaction worth $180,002.
RxSight Inc (RXST) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 7.06% per share during the next fiscal year.
RxSight Inc (NASDAQ: RXST) Trading Performance Indicators
You can see what RxSight Inc (RXST) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 10.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.71, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.50 in one year’s time.
Technical Analysis of RxSight Inc (RXST)
Let’s dig in a bit further. During the last 5-days, its volume was 0.95 million. That was better than the volume of 0.78 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 23.83%. Additionally, its Average True Range was 1.42.
During the past 100 days, RxSight Inc’s (RXST) raw stochastic average was set at 2.38%, which indicates a significant decrease from 6.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 200.62% in the past 14 days, which was higher than the 90.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $24.13, while its 200-day Moving Average is $40.12. However, in the short run, RxSight Inc’s stock first resistance to watch stands at $14.61. Second resistance stands at $14.89. The third major resistance level sits at $15.17. If the price goes on to break the first support level at $14.05, it is likely to go to the next support level at $13.77. Assuming the price breaks the second support level, the third support level stands at $13.49.
RxSight Inc (NASDAQ: RXST) Key Stats
There are 40,491K outstanding shares of the company, which has a market capitalization of 579.83 million. As of now, sales total 139,930 K while income totals -27,460 K. Its latest quarter income was 40,210 K while its last quarter net income were -5,940 K.
